Dendritic Cells Archive - Seite 27 von 107 - IOZK

Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines

2018-10-12/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2018-10-12 / Hum Vaccin Immunother 2019;15(2):397-406

Dendritic cell vaccine with Ag85A enhances anti-colorectal carcinoma immunity

2018-10-11/in Colorectal Cancer, Dendritic Cells, International Publications /von 2018-10-11 / Exp Ther Med 2018 Dec;16(6):5123-5129

Phase I/II clinical trial of a Wilms‘ tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer

2018-10-10/in Dendritic Cells, International Publications /von 2018-10-10 / Cancer Immunol. Immunother. 2019 Jan;68(1):121-130

Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time

2018-10-01/in Checkpoint-Inhibitors, Dendritic Cells, International Publications /von 2018-10-01 / Front Immunol 2018;9:2265

Combining Tumor Vaccination and Oncolytic Viral Approaches with Checkpoint Inhibitors: Rationale, Pre-Clinical Experience, and Current Clinical Trials in Malignant Melanoma

2018-10-01/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Malignant Melanoma, Newcastle Disease Virus /von 2018-10-01 / Am J Clin Dermatol 2018 Oct;19(5):657-670

A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis

2018-09-29/in Colorectal Cancer, Dendritic Cells, International Publications /von 2018-09-29 / J Immunother Cancer 2018 Sep;6(1):96

Recombinant Newcastle disease virus expressing human IFN-λ1 (rL-hIFN-λ1)-induced apoptosis of A549 cells is connected to endoplasmic reticulum stress pathways

2018-09-23/in Dendritic Cells, International Publications, NSCLC /von 2018-09-23 / Thorac Cancer 2018 Nov;9(11):1437-1452

Autologous Dendritic Cell Therapy in Mesothelioma Patients Enhances Frequencies of Peripheral CD4 T Cells Expressing HLA-DR, PD-1, or ICOS

2018-09-07/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2018-09-07 / Front Immunol 2018;9:2034

Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4 T-lymphocyte counts

2018-08-29/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von 2018-08-29 / CNS Oncol 2018 07;7(3):CNS22

Further clinical advancement of dendritic cell vaccination against ovarian cancer

2018-08-23/in Dendritic Cells, International Publications, Ovarian Cancer /von 2018-08-23 / Ann Res Hosp 2018 Aug;2